InflaRx NV (IFRX)
2.22
-0.01
(-0.45%)
USD |
NASDAQ |
Sep 04, 16:00
2.22
0.00 (0.00%)
Pre-Market: 20:00
InflaRx SG&A Expense (TTM) : 16.14M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.14M |
| March 31, 2026 | 20.00M |
| September 30, 2025 | 21.12M |
| June 30, 2025 | 22.14M |
| March 31, 2025 | 22.73M |
| September 30, 2024 | 20.97M |
| June 30, 2024 | 20.86M |
| March 31, 2024 | 19.58M |
| December 31, 2023 | 17.98M |
| September 30, 2023 | 15.99M |
| June 30, 2023 | 14.24M |
| March 31, 2023 | 14.72M |
| December 31, 2022 | 15.77M |
| September 30, 2022 | 15.94M |
| June 30, 2022 | 16.83M |
| March 31, 2022 | 15.46M |
| December 31, 2021 | 14.17M |
| September 30, 2021 | 13.77M |
| June 30, 2021 | 11.13M |
| March 31, 2021 | 10.44M |
| December 31, 2020 | 9.624M |
| Date | Value |
|---|---|
| September 30, 2020 | 10.14M |
| June 30, 2020 | 11.55M |
| March 31, 2020 | 13.08M |
| December 31, 2019 | 14.01M |
| September 30, 2019 | 14.71M |
| June 30, 2019 | 15.48M |
| March 31, 2019 | 15.14M |
| December 31, 2018 | 15.09M |
| September 30, 2018 | 13.34M |
| June 30, 2018 | 10.50M |
| March 31, 2018 | 7.301M |
| December 31, 2017 | 4.206M |
| September 30, 2017 | 1.863M |
| June 30, 2017 | 1.167M |
| March 31, 2017 | 0.8836M |
| December 31, 2016 | 0.537M |
| September 30, 2016 | 0.537M |
| June 30, 2016 | 0.537M |
| March 31, 2016 | 0.2514M |
| December 31, 2015 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| MediGene AG | -- |
| BioNTech SE | 833.57M |
| Immatics NV | 63.90M |
| Beam Therapeutics, Inc. | 125.40M |
| Kymera Therapeutics, Inc. | 75.75M |